1. Quantification of urinary 18-hydroxycortisol using LC-MS/MS
- Author
-
Seiji Takeda, Yuji Takahashi, Shigeki Jin, Shu-Ping Hui, Toshihiro Sakurai, Shigeo Ikegawa, Katsuyuki Yanagisawa, Masato Fujikawa, Norio Wada, Hitoshi Chiba, Hirotoshi Fuda, and Takao Kurosawa
- Subjects
Adenoma ,medicine.medical_specialty ,Hydrocortisone ,Urinary system ,Clinical Biochemistry ,Adrenal Gland Neoplasms ,18-Hydroxycortisol ,Urine ,Essential hypertension ,Excretion ,Limit of Detection ,Tandem Mass Spectrometry ,Internal medicine ,Hyperaldosteronism ,Lc ms ms ,Biomarkers, Tumor ,medicine ,Humans ,In patient ,Aldosterone ,Solid Phase Microextraction ,Chromatography ,Chemistry ,Selected reaction monitoring ,Reproducibility of Results ,General Medicine ,medicine.disease ,Endocrinology ,Hypertension ,Essential Hypertension ,Chromatography, Liquid - Abstract
Background Urinary 18-hydroxycortisol has been investigated as a marker of aldosterone-producing adenoma (APA). The aim of this study was to develop and validate a method for the measurement of 18-hydroxycortisol using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Methods Urine was collected over a 24-hour period in patients with APA ( n = 11), idiopathic hyperaldosteronism (IHA, n = 9), and essential hypertension (EH, n = 6). 18-Hydroxycortisol was extracted in solid-phase, and measured by LC-MS/MS based on selected reaction monitoring. Results The method allowed quantification of 18-hydroxycortisol with a lower quantification limit of 0.26 nmol/L, intra- and inter-assay coefficients of variation of Conclusions The proposed method met the basic analytical requirements and was considered to be useful in the screening and differential diagnosis of APA.
- Published
- 2013